Stifel Financial’s Standard BioTools LAB Stock Holding History

Stifel Financial’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-83,035	Closed	-$2.44M	–	2280
2014 Q2	$2.44M	Buy	83,035 +9,886	+14%	+$317K	0.02%	694
2014 Q1	$3.22M	Buy	+73,149	New	+$3.22M	0.03%	593

Other funds holding LAB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stifel Financial's LAB Position: Q3 2014 in Review

Stifel Financial sold out of Standard BioTools (LAB) in Q3 2014, closing a stake of 83,035 shares — an estimated $2.44M sold.

Stifel Financial first reported a position in LAB in Q1 2014 and held it in 2 quarters. The position peaked at $3.22M in Q1 2014. 99 funds tracked by Wall St. Rank hold LAB as of Q3 2014.

Stifel Financial reported no remaining Standard BioTools position as of Q3 2014 after selling out during the quarter.
Stifel Financial sold 83,035 Standard BioTools shares in Q3 2014, an estimated $2.44M.
Stifel Financial first reported a position in Standard BioTools in Q1 2014 and held it in 2 quarters.
Stifel Financial's Standard BioTools position peaked at $3.22M in Q1 2014.
99 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2014.

Based on Stifel Financial's 13F filing for Q3 2014, filed 13 Nov 2014.